NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication] Neuromodulation by the immune system: implications for brain-directed immunotherapy

July 28, 2025

Co-authored by a Bio2Q researcher, this Review explores how the brain-immune axis acts as a key regulator of brain function and behavior through direct interactions with neural circuits. This work highlights how immunotherapies targeting neuroimmune pathways may offer therapeutic potential for psychiatric and neurological conditions.

Title Neuromodulation by the immune system: implications for brain-directed immunotherapy
Authors Daniel H Cho [1],[2], Jun R Huh [3], [4],[5], Gloria B Choi [1],[2]
Short Description This Review article, co-authored by a Bio2Q researcher, explores the growing recognition of the brain-immune axis as an important modulator of brain function and behavior, challenging the traditional view of the brain as immunologically isolated. This piece highlights how immune molecules, including cytokines and chemokines, influence neural activity, learning, memory, social behavior, and stress responses. The authors discuss the therapeutic potential of immunomodulatory approaches for neurological and psychiatric conditions, drawing on evidence from both animal models and clinical studies. This Review emphasizes recent findings that show immune signaling is a compelling target for brain-directed immunotherapy, and will provide a valuable resource that can be used to guide future research in neuroimmunology.
DOI https://doi.org/10.1016/j.coi.2025.102568.
Journal Current Opinion in Immunology
Vol/Num/Page Volume 95, 102568
Publication Date 2025 June 6.

Affiliations:
[1] Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA
[2] Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
[3] Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
[4] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan
[5] Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA, USA

More Bio2Q News

EVENT
2026.02.06

【2/25Seminar】WPI-Bio2Q Open Seminar: Andrew Wray, PhD

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...

ANNOUNCEMENT
2026.01.30

Two New Titles Released in the “Booklets Series for Young Readers” : Issue 09 (T...

The Digital Booklet Series for Young Readers, which introduces research activities at Bio2Q, has added two new issues. Issue 09 features ...

ANNOUNCEMENT
2026.01.29

WPI-Bio2Q Newsletter "Bio2Q Connect" Vol.2, Issue 13 Released

WPI-Bio2Q has published the latest issue of its newsletter, “Bio2Q Connect” (Vol. 2, Issue 13, January 29, 2026). This issue covers a broad ...

ANNOUNCEMENT
2026.01.28

Open Call: Postdoctoral Fellow for Professor Nadinath Nillegoda’s Lab

Prof. Nadinath Nillegoda, specializing in proteostasis and cell repair, is currently hiring a postdoctoral fellow. We are looking for appli...

EVENT
2026.01.19

【CHO School Series】Exploring the Frontiers of Life Science: A Special 3-Part Onl...

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q)  in collaboration with Knowledge Capital, will host a three-par...